ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2016

Possible determinants of VSL#3 probiotic failure in preventing gastrointestinal adverse events associated with dacomitinib in patients with advanced non-small-cell lung cancer enrolled in ARCHER-1042 trial.

G Ceccarelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.